| Wellgistics Health, Inc. (WGRX) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | Q1-CY2014 | Q4-CY2013 | |
| Balance Sheet Date | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | |||||||||||||||||||||||||||||||||||||||||||||
| Fiscal Period | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | |||||||||||||||||||||||||||||||||||||||||||||
| Operating Cash Flow | (1,135,329$) | (2,078,998$) | (1,347,449$) | (2,623,777$) | 1,037,591$ | 329,956$ | 31,237$ | ||||||||||||||||||||||||||||||||||||||||||
| Investing Cash Flow | (221,085$) | (131,926$) | (273,133$) | 802,554$ | (315,937$) | ||||||||||||||||||||||||||||||||||||||||||||
| Purchases of Property and Equipment | |||||||||||||||||||||||||||||||||||||||||||||||||
| Financing Cash Flow | 5,165,138$ | 114,281$ | 3,108,831$ | 2,056,411$ | 4,519$ | (538,037$) | 260,000$ | ||||||||||||||||||||||||||||||||||||||||||
| End Cash Position | 4,228,666$ | 419,942$ | 2,516,585$ | 1,028,336$ | 1,364$ | ||||||||||||||||||||||||||||||||||||||||||||
| Exchange Rate Effect | |||||||||||||||||||||||||||||||||||||||||||||||||
| Dividends Paid | |||||||||||||||||||||||||||||||||||||||||||||||||
| Unlevered Free Cash Flow | (1,135,329$) | (2,078,998$) | (1,347,449$) | (2,623,777$) | 1,037,591$ | 329,956$ | 31,237$ | ||||||||||||||||||||||||||||||||||||||||||